News
MYMD
2.860
+11.72%
0.300
Weekly Report: what happened at MYMD last week (0415-0419)?
Weekly Report · 2d ago
Weekly Report: what happened at MYMD last week (0408-0412)?
Weekly Report · 04/15 12:23
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Tilray Brands, Inc. (NASDAQ:TLRY) fell sharply during Tuesday's session. The company missed third-quarter estimates and said it no longer expects to generate positive free cash flow for the full fiscal year 2024. Laser Photonics Corporation shares climbed 168% to $3.82.
Benzinga · 04/09 17:12
Molecular Templates, Acorda Therapeutics, MyMD Pharmaceuticals among healthcare movers
Molecular Templates, Acorda Therapeutics, MyMD Pharmaceuticals among healthcare movers. S&P 500 Health Care Sector +0.11% to 1666.38. Pharmaceuticals, Biotechnology & Life Science contributes 58% to index.
Seeking Alpha · 04/09 14:00
MyMD Pharmaceuticals Filing From Late Monday Shows Co. Entered Omnibus Waiver And Amendment Agreement With Required Holders Under Previously Announced Securities Purchase Agreement
MyMD Pharmaceuticals, Inc. Entered into a Securities Purchase Agreement with certain accredited investors on February 21, 2023. The Company agreed to sell to the Holders shares of the Company's Series F Convertible Preferred Stock. The holders of the Preferred Shares will be entitled to vote with the holders of common stock.
Benzinga · 04/09 13:30
Why Is Vivos Therapeutics (VVOS) Stock Up 16% Today?
Vivos Therapeutics stock is up 15.5% as of Tuesday morning. The company has received full reimbursement for devices for obstructive sleep apnea through Medicare. Vincerx Pharma, MyMD Pharmaceuticals and Trump Media & Technology stock are also in the news.
Investorplace · 04/09 12:53
Why Is Vincerx Pharma (VINC) Stock Down 64% Today?
Vincerx Pharma’s cancer treatments did so potential in preliminary study results. Seven of the 15 VNC-236-101 patients achieve stable disease. The company believes there is more potential for the treatment. VINC stock is down 64.4% as of Tuesday morning.
Investorplace · 04/09 12:40
Why Is MyMD Pharmaceuticals (MYMD) Stock Up 35% Today?
MyMD Pharmaceuticals (NASDAQ:MYMD) stock is up 35.3% on Tuesday. The company announced a new amendment to a securities purchase agreement with preferred shareholders. MYMD stock has more than 4 million shares changing hands as of Tuesday morning. Biophytis stock is also up 43% in the pre-market today. We have all of the hottest stock market news for Tuesday.
Investorplace · 04/09 12:21
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Acrivon Therapeutics (NASDAQ:ACRV) stock moved upwards by 72.3% to $10.19 during Tuesday's pre-market session. MyMD Pharmaceuticals stock rose 33.85% and Addex Therapeutic stock rose 24.48% during the same session. Other gainers included Vincerx Pharma, Neogen and Tilray Brands.
Benzinga · 04/09 12:09
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are worth checking out on Tuesday morning. Biophytis stock is rocketing close to 50% after announcing its 2023 results. Moving stocks this morning are earnings reports, clinical trial data and more. Biggest Pre-Market Stock Movers include 10 top gainers and 10 top losers.
Investorplace · 04/09 11:27
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
Biophytis S.A. Posted a FY23 loss of €0.03 per share. MyMD Pharmaceuticals, Inc. Shares rose 40% in pre-market trading after jumping 22% on Monday. Biophytis shares jumped 55.2% to $0.4920 in today's pre- market trading.
Benzinga · 04/09 10:05
MyMD Pharmaceuticals Enhances Governance and Financing Structure
TipRanks · 04/08 21:02
MYMD PHARMACEUTICALS INC - EFFECTIVE AS OF APRIL 8, CO INCREASED AUTHORIZED NUMBER OF DIRECTORS FROM SIX TO SEVEN
Reuters · 04/08 20:51
Weekly Report: what happened at MYMD last week (0401-0405)?
Weekly Report · 04/08 12:29
Weekly Report: what happened at MYMD last week (0325-0329)?
Weekly Report · 04/01 12:24
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic on Thursday. Avalo Therapeutics stock is rocketing more than 268% after announcing a $185 million private placement. Moving stocks this morning are public debuts, earnings reports and more. Ten of the biggest pre-market stocks moving shares this morning.
Investorplace · 03/28 11:43
Weekly Report: what happened at MYMD last week (0318-0322)?
Weekly Report · 03/25 12:28
Weekly Report: what happened at MYMD last week (0311-0315)?
Weekly Report · 03/18 12:26
Weekly Report: what happened at MYMD last week (0304-0308)?
Weekly Report · 03/11 12:21
More
Webull provides a variety of real-time MYMD stock news. You can receive the latest news about Mymd Pharmaceuticals Inc through multiple platforms. This information may help you make smarter investment decisions.
About MYMD
MyMD Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing two novel therapeutic platforms that treat the causes of disease rather than only addressing the symptoms. The Company’s MYMD-1 is a drug platform based on a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. MYMD-1 is being developed to delay aging, increase longevity, and treat autoimmune diseases. It also shows potential as an anti-fibrotic and anti-prolific therapeutic. The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction, and epilepsy. Supera-CBD is a synthetic, preclinical cannabidiol derivative that has been demonstrated to effectively target cannabinoid type 2 (CB2) receptors. Supera-CBD binds to and inhibits opioid receptors, comparing it side by side with plant-based cannabidiol (CBD).